Loading…

Patient-reported problems filling buprenorphine prescriptions and motivations for illicit use

•34% of subjects in treatment had problems filling their buprenorphine prescription.•Few (8/51) subjects in treatment reported using illicit buprenorphine to get high.•Subjects with problems filling prescriptions were more likely to report illicit use. While barriers to accessing buprenorphine (BUP)...

Full description

Saved in:
Bibliographic Details
Published in:Drug and alcohol dependence reports 2022-12, Vol.5, p.100091-100091, Article 100091
Main Authors: Winstanley, Erin L., Thacker, Emily P., Choo, Lyn Yuen, Lander, Laura R., Berry, James H., Tofighi, Babak
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c451t-e1c7b960c9641df4172b0e4912ef9c5b6728efd631739d9be5401586da255c0b3
cites cdi_FETCH-LOGICAL-c451t-e1c7b960c9641df4172b0e4912ef9c5b6728efd631739d9be5401586da255c0b3
container_end_page 100091
container_issue
container_start_page 100091
container_title Drug and alcohol dependence reports
container_volume 5
creator Winstanley, Erin L.
Thacker, Emily P.
Choo, Lyn Yuen
Lander, Laura R.
Berry, James H.
Tofighi, Babak
description •34% of subjects in treatment had problems filling their buprenorphine prescription.•Few (8/51) subjects in treatment reported using illicit buprenorphine to get high.•Subjects with problems filling prescriptions were more likely to report illicit use. While barriers to accessing buprenorphine (BUP) therapy have been well described, little is known about pharmacy-related barriers. The objective of this study was to estimate the prevalence of patient-reported problems filling BUP prescriptions and determine whether these problems were associated with illicit use of BUP. The secondary objectives included identifying motivations for illicit BUP use and the prevalence of naloxone acquisition among patients prescribed BUP. Between July 2019 and March 2020, 139 participants receiving treatment for an opioid use disorder (OUD) at two sites within a rurally-located health system, completed an anonymous 33-item survey. A multivariable model was used to assess the association between pharmacy-related problems filling BUP prescriptions and illicit substance use. More than a third of participants reported having problems filling their BUP prescription (34.1%, n = 47) with the most commonly reported problems being insufficient pharmacy stock of BUP (37.8%, n = 17), pharmacist refusal to dispense BUP (37.8%, n = 17), and insurance problems (34.0%, n = 16). Of those who reported illicit BUP use (41.5%, n = 56), the most common motivations were to avoid/ease withdrawal symptoms (n = 39), prevent/reduce cravings (n = 39), maintain abstinence (n = 30), and treat pain (n = 19). In the multivariable model, participants who reported a pharmacy-related problems were significantly more likely to use illicitly obtained BUP (OR=8.93, 95% CI: 3.12, 25.52, p 
doi_str_mv 10.1016/j.dadr.2022.100091
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_b50ca501a13f40f695b53be44bacd43a</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S277272462200066X</els_id><doaj_id>oai_doaj_org_article_b50ca501a13f40f695b53be44bacd43a</doaj_id><sourcerecordid>2780486747</sourcerecordid><originalsourceid>FETCH-LOGICAL-c451t-e1c7b960c9641df4172b0e4912ef9c5b6728efd631739d9be5401586da255c0b3</originalsourceid><addsrcrecordid>eNp9kU1rFTEUhoMottT-ARcySzdzTTL5mIAIUvwoFHShSwn5OHOby8xkTDIX-u_NdWppN66SnPOe54T3Reg1wTuCiXh32Hnj045iSmsBY0WeoXMqJW0lZeL5o_sZusz5UCW0r0IpXqKzTvSMESHO0a_vpgSYS5tgiamAb5YU7QhTboYwjmHeN3ZdEswxLbdhhtqG7FJYSohzbszsmymWcDTbe4ipOY25UJo1wyv0YjBjhsv78wL9_Pzpx9XX9ubbl-urjzetY5yUFoiTVgnslGDED4xIajEwRSgMynErJO1h8KIjslNeWeAME94LbyjnDtvuAl1vXB_NQS8pTCbd6WiC_luIaa9NKsGNoC3HznBMDOkGhgehuOWdBcascZ51prI-bKxltRN4V81JZnwCfdqZw63ex6NWiqmuExXw9h6Q4u8VctFTyA7G0cwQ16yp7DHrhWSySukmdSnmnGB4WEOwPsWsD_oUsz7FrLeY69Cbxx98GPkXahW83wRQLT8GSDq7mrEDHxK4Uj0J_-P_AWIXu0A</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2780486747</pqid></control><display><type>article</type><title>Patient-reported problems filling buprenorphine prescriptions and motivations for illicit use</title><source>ScienceDirect</source><source>PubMed Central Free</source><creator>Winstanley, Erin L. ; Thacker, Emily P. ; Choo, Lyn Yuen ; Lander, Laura R. ; Berry, James H. ; Tofighi, Babak</creator><creatorcontrib>Winstanley, Erin L. ; Thacker, Emily P. ; Choo, Lyn Yuen ; Lander, Laura R. ; Berry, James H. ; Tofighi, Babak</creatorcontrib><description>•34% of subjects in treatment had problems filling their buprenorphine prescription.•Few (8/51) subjects in treatment reported using illicit buprenorphine to get high.•Subjects with problems filling prescriptions were more likely to report illicit use. While barriers to accessing buprenorphine (BUP) therapy have been well described, little is known about pharmacy-related barriers. The objective of this study was to estimate the prevalence of patient-reported problems filling BUP prescriptions and determine whether these problems were associated with illicit use of BUP. The secondary objectives included identifying motivations for illicit BUP use and the prevalence of naloxone acquisition among patients prescribed BUP. Between July 2019 and March 2020, 139 participants receiving treatment for an opioid use disorder (OUD) at two sites within a rurally-located health system, completed an anonymous 33-item survey. A multivariable model was used to assess the association between pharmacy-related problems filling BUP prescriptions and illicit substance use. More than a third of participants reported having problems filling their BUP prescription (34.1%, n = 47) with the most commonly reported problems being insufficient pharmacy stock of BUP (37.8%, n = 17), pharmacist refusal to dispense BUP (37.8%, n = 17), and insurance problems (34.0%, n = 16). Of those who reported illicit BUP use (41.5%, n = 56), the most common motivations were to avoid/ease withdrawal symptoms (n = 39), prevent/reduce cravings (n = 39), maintain abstinence (n = 30), and treat pain (n = 19). In the multivariable model, participants who reported a pharmacy-related problems were significantly more likely to use illicitly obtained BUP (OR=8.93, 95% CI: 3.12, 25.52, p &lt; 0.0001). Efforts to improve BUP access have primarily focused on increasing the number of clinicians waivered to prescribe; however, challenges persist with BUP dispensing and coordinated efforts may be needed to systematically reduce pharmacy-related barriers.</description><identifier>ISSN: 2772-7246</identifier><identifier>EISSN: 2772-7246</identifier><identifier>DOI: 10.1016/j.dadr.2022.100091</identifier><identifier>PMID: 36844166</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Buprenorphine ; Diversion ; Full Length Report ; Naloxone ; Opioid use disorder</subject><ispartof>Drug and alcohol dependence reports, 2022-12, Vol.5, p.100091-100091, Article 100091</ispartof><rights>2022</rights><rights>2022 The Authors. Published by Elsevier B.V.</rights><rights>2022 The Authors. Published by Elsevier B.V. 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c451t-e1c7b960c9641df4172b0e4912ef9c5b6728efd631739d9be5401586da255c0b3</citedby><cites>FETCH-LOGICAL-c451t-e1c7b960c9641df4172b0e4912ef9c5b6728efd631739d9be5401586da255c0b3</cites><orcidid>0000-0003-3571-0259 ; 0000-0001-5640-0749</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9949336/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S277272462200066X$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,3549,27924,27925,45780,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36844166$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Winstanley, Erin L.</creatorcontrib><creatorcontrib>Thacker, Emily P.</creatorcontrib><creatorcontrib>Choo, Lyn Yuen</creatorcontrib><creatorcontrib>Lander, Laura R.</creatorcontrib><creatorcontrib>Berry, James H.</creatorcontrib><creatorcontrib>Tofighi, Babak</creatorcontrib><title>Patient-reported problems filling buprenorphine prescriptions and motivations for illicit use</title><title>Drug and alcohol dependence reports</title><addtitle>Drug Alcohol Depend Rep</addtitle><description>•34% of subjects in treatment had problems filling their buprenorphine prescription.•Few (8/51) subjects in treatment reported using illicit buprenorphine to get high.•Subjects with problems filling prescriptions were more likely to report illicit use. While barriers to accessing buprenorphine (BUP) therapy have been well described, little is known about pharmacy-related barriers. The objective of this study was to estimate the prevalence of patient-reported problems filling BUP prescriptions and determine whether these problems were associated with illicit use of BUP. The secondary objectives included identifying motivations for illicit BUP use and the prevalence of naloxone acquisition among patients prescribed BUP. Between July 2019 and March 2020, 139 participants receiving treatment for an opioid use disorder (OUD) at two sites within a rurally-located health system, completed an anonymous 33-item survey. A multivariable model was used to assess the association between pharmacy-related problems filling BUP prescriptions and illicit substance use. More than a third of participants reported having problems filling their BUP prescription (34.1%, n = 47) with the most commonly reported problems being insufficient pharmacy stock of BUP (37.8%, n = 17), pharmacist refusal to dispense BUP (37.8%, n = 17), and insurance problems (34.0%, n = 16). Of those who reported illicit BUP use (41.5%, n = 56), the most common motivations were to avoid/ease withdrawal symptoms (n = 39), prevent/reduce cravings (n = 39), maintain abstinence (n = 30), and treat pain (n = 19). In the multivariable model, participants who reported a pharmacy-related problems were significantly more likely to use illicitly obtained BUP (OR=8.93, 95% CI: 3.12, 25.52, p &lt; 0.0001). Efforts to improve BUP access have primarily focused on increasing the number of clinicians waivered to prescribe; however, challenges persist with BUP dispensing and coordinated efforts may be needed to systematically reduce pharmacy-related barriers.</description><subject>Buprenorphine</subject><subject>Diversion</subject><subject>Full Length Report</subject><subject>Naloxone</subject><subject>Opioid use disorder</subject><issn>2772-7246</issn><issn>2772-7246</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNp9kU1rFTEUhoMottT-ARcySzdzTTL5mIAIUvwoFHShSwn5OHOby8xkTDIX-u_NdWppN66SnPOe54T3Reg1wTuCiXh32Hnj045iSmsBY0WeoXMqJW0lZeL5o_sZusz5UCW0r0IpXqKzTvSMESHO0a_vpgSYS5tgiamAb5YU7QhTboYwjmHeN3ZdEswxLbdhhtqG7FJYSohzbszsmymWcDTbe4ipOY25UJo1wyv0YjBjhsv78wL9_Pzpx9XX9ubbl-urjzetY5yUFoiTVgnslGDED4xIajEwRSgMynErJO1h8KIjslNeWeAME94LbyjnDtvuAl1vXB_NQS8pTCbd6WiC_luIaa9NKsGNoC3HznBMDOkGhgehuOWdBcascZ51prI-bKxltRN4V81JZnwCfdqZw63ex6NWiqmuExXw9h6Q4u8VctFTyA7G0cwQ16yp7DHrhWSySukmdSnmnGB4WEOwPsWsD_oUsz7FrLeY69Cbxx98GPkXahW83wRQLT8GSDq7mrEDHxK4Uj0J_-P_AWIXu0A</recordid><startdate>20221201</startdate><enddate>20221201</enddate><creator>Winstanley, Erin L.</creator><creator>Thacker, Emily P.</creator><creator>Choo, Lyn Yuen</creator><creator>Lander, Laura R.</creator><creator>Berry, James H.</creator><creator>Tofighi, Babak</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>6I.</scope><scope>AAFTH</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0003-3571-0259</orcidid><orcidid>https://orcid.org/0000-0001-5640-0749</orcidid></search><sort><creationdate>20221201</creationdate><title>Patient-reported problems filling buprenorphine prescriptions and motivations for illicit use</title><author>Winstanley, Erin L. ; Thacker, Emily P. ; Choo, Lyn Yuen ; Lander, Laura R. ; Berry, James H. ; Tofighi, Babak</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c451t-e1c7b960c9641df4172b0e4912ef9c5b6728efd631739d9be5401586da255c0b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Buprenorphine</topic><topic>Diversion</topic><topic>Full Length Report</topic><topic>Naloxone</topic><topic>Opioid use disorder</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Winstanley, Erin L.</creatorcontrib><creatorcontrib>Thacker, Emily P.</creatorcontrib><creatorcontrib>Choo, Lyn Yuen</creatorcontrib><creatorcontrib>Lander, Laura R.</creatorcontrib><creatorcontrib>Berry, James H.</creatorcontrib><creatorcontrib>Tofighi, Babak</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals</collection><jtitle>Drug and alcohol dependence reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Winstanley, Erin L.</au><au>Thacker, Emily P.</au><au>Choo, Lyn Yuen</au><au>Lander, Laura R.</au><au>Berry, James H.</au><au>Tofighi, Babak</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Patient-reported problems filling buprenorphine prescriptions and motivations for illicit use</atitle><jtitle>Drug and alcohol dependence reports</jtitle><addtitle>Drug Alcohol Depend Rep</addtitle><date>2022-12-01</date><risdate>2022</risdate><volume>5</volume><spage>100091</spage><epage>100091</epage><pages>100091-100091</pages><artnum>100091</artnum><issn>2772-7246</issn><eissn>2772-7246</eissn><abstract>•34% of subjects in treatment had problems filling their buprenorphine prescription.•Few (8/51) subjects in treatment reported using illicit buprenorphine to get high.•Subjects with problems filling prescriptions were more likely to report illicit use. While barriers to accessing buprenorphine (BUP) therapy have been well described, little is known about pharmacy-related barriers. The objective of this study was to estimate the prevalence of patient-reported problems filling BUP prescriptions and determine whether these problems were associated with illicit use of BUP. The secondary objectives included identifying motivations for illicit BUP use and the prevalence of naloxone acquisition among patients prescribed BUP. Between July 2019 and March 2020, 139 participants receiving treatment for an opioid use disorder (OUD) at two sites within a rurally-located health system, completed an anonymous 33-item survey. A multivariable model was used to assess the association between pharmacy-related problems filling BUP prescriptions and illicit substance use. More than a third of participants reported having problems filling their BUP prescription (34.1%, n = 47) with the most commonly reported problems being insufficient pharmacy stock of BUP (37.8%, n = 17), pharmacist refusal to dispense BUP (37.8%, n = 17), and insurance problems (34.0%, n = 16). Of those who reported illicit BUP use (41.5%, n = 56), the most common motivations were to avoid/ease withdrawal symptoms (n = 39), prevent/reduce cravings (n = 39), maintain abstinence (n = 30), and treat pain (n = 19). In the multivariable model, participants who reported a pharmacy-related problems were significantly more likely to use illicitly obtained BUP (OR=8.93, 95% CI: 3.12, 25.52, p &lt; 0.0001). Efforts to improve BUP access have primarily focused on increasing the number of clinicians waivered to prescribe; however, challenges persist with BUP dispensing and coordinated efforts may be needed to systematically reduce pharmacy-related barriers.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>36844166</pmid><doi>10.1016/j.dadr.2022.100091</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0003-3571-0259</orcidid><orcidid>https://orcid.org/0000-0001-5640-0749</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2772-7246
ispartof Drug and alcohol dependence reports, 2022-12, Vol.5, p.100091-100091, Article 100091
issn 2772-7246
2772-7246
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_b50ca501a13f40f695b53be44bacd43a
source ScienceDirect; PubMed Central Free
subjects Buprenorphine
Diversion
Full Length Report
Naloxone
Opioid use disorder
title Patient-reported problems filling buprenorphine prescriptions and motivations for illicit use
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T19%3A23%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Patient-reported%20problems%20filling%20buprenorphine%20prescriptions%20and%20motivations%20for%20illicit%20use&rft.jtitle=Drug%20and%20alcohol%20dependence%20reports&rft.au=Winstanley,%20Erin%20L.&rft.date=2022-12-01&rft.volume=5&rft.spage=100091&rft.epage=100091&rft.pages=100091-100091&rft.artnum=100091&rft.issn=2772-7246&rft.eissn=2772-7246&rft_id=info:doi/10.1016/j.dadr.2022.100091&rft_dat=%3Cproquest_doaj_%3E2780486747%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c451t-e1c7b960c9641df4172b0e4912ef9c5b6728efd631739d9be5401586da255c0b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2780486747&rft_id=info:pmid/36844166&rfr_iscdi=true